Hida T - Search Results

1

Osimertinib in Japanese patients with EGFR T790M mutation-positive advanced non-small-cell lung cancer: AURA3 trial.

Akamatsu H, Katakami N, Okamoto I, Kato T, Kim YH, Imamura F, Shinkai M, Hodge RA, Uchida H, Hida T. Akamatsu H, et al. Among authors: hida t. Cancer Sci. 2018 Jun;109(6):1930-1938. doi: 10.1111/cas.13623. Epub 2018 May 31. Cancer Sci. 2018. PMID: 29697876 Free PMC article. Clinical Trial.

2

Preferential expression of c-kit protooncogene transcripts in small cell lung cancer.

Sekido Y, Obata Y, Ueda R, Hida T, Suyama M, Shimokata K, Ariyoshi Y, Takahashi T. Sekido Y, et al. Among authors: hida t. Cancer Res. 1991 May 1;51(9):2416-9. Cancer Res. 1991. PMID: 1707753

3

Expression and amplification of myc gene family in small cell lung cancer and its relation to biological characteristics.

Takahashi T, Obata Y, Sekido Y, Hida T, Ueda R, Watanabe H, Ariyoshi Y, Sugiura T, Takahashi T. Takahashi T, et al. Among authors: hida t. Cancer Res. 1989 May 15;49(10):2683-8. Cancer Res. 1989. PMID: 2540905

4

Chemosensitivity and radiosensitivity of small cell lung cancer cell lines studied by a newly developed 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) hybrid assay.

Hida T, Ueda R, Takahashi T, Watanabe H, Kato T, Suyama M, Sugiura T, Ariyoshi Y, Takahashi T. Hida T, et al. Cancer Res. 1989 Sep 1;49(17):4785-90. Cancer Res. 1989. PMID: 2547517

5

Ectopic expression of c-kit in small-cell lung cancer.

Hida T, Ueda R, Sekido Y, Hibi K, Matsuda R, Ariyoshi Y, Sugiura T, Takahashi T, Takahashi T. Hida T, et al. Int J Cancer Suppl. 1994;8:108-9. doi: 10.1002/ijc.2910570723. Int J Cancer Suppl. 1994. PMID: 7515024

6

Recombinant human stem cell factor mediates chemotaxis of small-cell lung cancer cell lines aberrantly expressing the c-kit protooncogene.

Sekido Y, Takahashi T, Ueda R, Takahashi M, Suzuki H, Nishida K, Tsukamoto T, Hida T, Shimokata K, Zsebo KM, et al. Sekido Y, et al. Among authors: hida t. Cancer Res. 1993 Apr 1;53(7):1709-14. Cancer Res. 1993. PMID: 7680956

7

Serum glutathione S-transferase-pi level as a tumor marker for non-small cell lung cancer. Potential predictive value in chemotherapeutic response.

Hida T, Kuwabara M, Ariyoshi Y, Takahashi T, Sugiura T, Hosoda K, Niitsu Y, Ueda R. Hida T, et al. Cancer. 1994 Mar 1;73(5):1377-82. doi: 10.1002/1097-0142(19940301)73:5<1377::aid-cncr2820730511>3.0.co;2-n. Cancer. 1994. PMID: 8111704 Clinical Trial.

8

Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines.

Hida T, Kozaki K, Muramatsu H, Masuda A, Shimizu S, Mitsudomi T, Sugiura T, Ogawa M, Takahashi T. Hida T, et al. Clin Cancer Res. 2000 May;6(5):2006-11. Clin Cancer Res. 2000. PMID: 10815926

9

The sensitivity of lung cancer cell lines to the EGFR-selective tyrosine kinase inhibitor ZD1839 ('Iressa') is not related to the expression of EGFR or HER-2 or to K-ras gene status.

Suzuki T, Nakagawa T, Endo H, Mitsudomi T, Masuda A, Yatabe Y, Sugiura T, Takahashi T, Hida T. Suzuki T, et al. Among authors: hida t. Lung Cancer. 2003 Oct;42(1):35-41. doi: 10.1016/s0169-5002(03)00278-2. Lung Cancer. 2003. PMID: 14512185

10

Establishment and characterization of four malignant pleural mesothelioma cell lines from Japanese patients.

Usami N, Fukui T, Kondo M, Taniguchi T, Yokoyama T, Mori S, Yokoi K, Horio Y, Shimokata K, Sekido Y, Hida T. Usami N, et al. Among authors: hida t. Cancer Sci. 2006 May;97(5):387-94. doi: 10.1111/j.1349-7006.2006.00184.x. Cancer Sci. 2006. PMID: 16630136 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

667 results

Search Page

Filters